Skip Navigation

This quarter, Bluesight acquired Protenus, further expanding our ability to help customers prevent and detect diversion and adding the newly rebranded patient privacy monitoring product, PrivacyPro, to our suite of solutions. Read our recent CEO blog on the exciting future of PrivacyPro here

We’re continually listening to our customers and adding new products and features that address ongoing pain points, providing a single-vendor experience that simplifies contracting, support, and implementation across multiple solutions. Some recent product launches include ControlCheck RetailCostCheck + Shortages, and KitCheck Anywhere. Read the rest of the newsletter to learn about all the new ways we’re simplifying workflows, demystifying data, and innovating hospital operations.

For years, we’ve heard from customers that drug shortages are a persistent and pressing issue in hospitals. And, while we cannot prevent drug shortages, with CostCheck + Shortages we can empower your team to respond efficiently and effectively, ultimately reducing the impact of shortages. 

Shortages Webinar Promo Email

To learn how hospitals leverage CostCheck + Shortages, Join us for a 30-minute fireside chat featuring Paige Schmidt, PharmD from Texas Children’s Hospital, and AJ Rivosecchi, PharmD from Bluesight. During the webinar, Paige and AJ will discuss lessons learned and new strategies for tackling drug shortages. Register here

For the fourth time, ControlCheck won Best In KLAS in the Drug Diversion Monitoring category, earning a top score of 86.1 from customers surveyed. And, for the third consecutive year, PrivacyPro (formerly Protenus) was named Best In KLAS in Patient Privacy Monitoring with an all-time-high score of 94.3. We are honored to be recognized for our ongoing commitment to providing industry-leading solutions and support for our customers. Read more here

Sentara Cardiac OR Cuts Costs & Stockouts with RFID Medication Tracking

Sentara Norfolk General Hospital faced inventory challenges with compounded cardiac medications, leading to waste, stockouts, and safety risks. By implementing KitCheck Anywhere’s RFID tracking system, the hospital reduced expirations by 86%, saved over $49,000 annually, eliminated stockouts, improved workflow efficiency, and enhanced medication safety.

2025 Breach Barometer

Understanding healthcare data breaches is critical to improving cybersecurity strategies for a safer, more secure future. Since 2016, the Breach Barometer report has tracked data breaches affecting U.S. patients and health data. 

The 2025 report shows that last year 1,160 breach reports were compiled, with 1,043 being new incidents. A staggering 305,527,355 patient records were breached—a sharp increase driven by a single catastrophic event. Explore the full report to uncover the key trends and lessons from this challenging year.

Diversion Quarterly, Q4 2024

The Diversion Quarterly is a publicly available resource that provides a snapshot of the industry based on aggregated data from over 1,150 ControlCheck customers to help hospitals benchmark their efforts. Notably, last quarter’s report shows a two-day increase in the average number of days to complete an investigation. Read the full report to see where your investigation data stacks up to the average. 

This quarter, we expanded our suite of solutions and released multiple new features. You can get an in-depth overview of any of our new products or features on your own time with our on-demand demos:

HealthSystemCIO Webinar: Keys to Implementing a Comprehensive Insider Threat Mitigation Program

March 25, 12:00 EST

Preventing and detecting insider threats is tricky business, as they arise from within the castle. In this timely webinar, we’ll hear from leaders sharing actionable insights to ensure threats from within get as much attention as threats from without.

Fireside Chat: Strategies for Measuring Success & Ensuring Compliance in Your 340B Program

March 31, 1:00 PM EST

Join Eric Manuel Balmir, VP of Clinical Ancillary Services & CPO at Children’s National Hospital, Ted Slafsky, CEO of 340B Report, and Lauren Forni, Senior Director of Clinical Strategy at Bluesight as they explore key strategies to build and sustain a successful 340B program in an ever-changing regulatory landscape.

Visit us at upcoming trade shows to learn how Bluesight can power your hospital operations through inventory management, procurement optimization, patient privacy, and diversion monitoring.